BERGE BIOMED AS has a total of 14 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Norway, Canada and China. Its main competitors in its focus markets pharmaceuticals and foods and drinks are VEIJLEN N V, BOILEAU THOMAS WILLIAM-MAXWELL and PHYTOPHARMA INT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Norway | 5 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | Republic of Korea | 2 | |
#5 | Chile | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Fodder | |
#4 | Special foods | |
#5 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Berge Rolf | 6 |
#2 | Berge Rolf Kristian | 5 |
#3 | Thomassen Magny | 4 |
#4 | Rorvik Kjell-Arne | 4 |
#5 | Kleppe Gunnar | 2 |
#6 | Rolf Berge | 2 |
#7 | Skorve Jon | 1 |
#8 | Rora Mia B | 1 |
#9 | Ruyter Bente | 1 |
#10 | Gunnar Kleppe | 1 |
Publication | Filing date | Title |
---|---|---|
EP1959751A2 | Use of fatty acid analogues | |
CN1845748A | Pharmaceutical use of fish protein hydrolyzate | |
KR20060079789A | Use of a single-cell protein material |